scispace - formally typeset
F

Francesco E. Pontieri

Researcher at Sapienza University of Rome

Publications -  140
Citations -  8326

Francesco E. Pontieri is an academic researcher from Sapienza University of Rome. The author has contributed to research in topics: Parkinson's disease & Dopaminergic. The author has an hindex of 35, co-authored 128 publications receiving 7542 citations. Previous affiliations of Francesco E. Pontieri include National Institutes of Health & University of Cagliari.

Papers
More filters
Journal ArticleDOI

Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs

TL;DR: It is reported that intravenous nicotine in the rat, at doses known to maintain self-administration, stimulates local energy metabolism, as measured by 2-deoxyglucose autoradiography, and dopamine transmission, as estimated by brain microdialysis, in the shell of the nucleus accumbens.
Journal ArticleDOI

Cannabinoid and Heroin Activation of Mesolimbic Dopamine Transmission by a Common µ1 Opioid Receptor Mechanism

TL;DR: Delta9-THC and heroin exert similar effects on mesolimbic dopamine transmission through a common mu1 opioid receptor mechanism located in the ventral mesencephalic tegmentum.
Journal ArticleDOI

Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens

TL;DR: In vivo neurochemical evidence is provided for a functional compartmentation within the nucleus accumbens and for a preferential effect of psychostimulants and morphine in the shell of the nucleus Accumbens at doses known to sustain intravenous drug self-administration.
Journal ArticleDOI

Magnetic resonance imaging markers of Parkinson’s disease nigrostriatal signature

TL;DR: Parkinson-associated physiopathological modifications were characterized in six subcortical structures by simultaneously measuring quantitative magnetic resonance parameters sensitive to complementary tissue characteristics, demonstrating that multimodal magnetic resonance imaging of sub cortical grey matter structures is useful for the evaluation of Parkinson's disease and, possibly, of other subcortsical pathologies.